Skip to content

Validation of ICG-99mTc-nanoscan as hybrid tracer for sentinel node biopsy - NANOSCAN

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519351-28-00
Enrollment
29
Registered
2024-12-16
Start date
2023-11-15
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral malignancies or penile carcinoma who are scheduled for a sentinel node (SN) biopsy., Patients with melanoma of the head/neck or the upper part of the trunk

Brief summary

To demonstrate concordance between the SN visualization of 99mTc-nanoscan and ICG-99mTc-nanoscan on preoperative lymphoscintigraphy and SPECT/CT imaging, expecting an average of 3 sentinel nodes per patient. Discordance is defined as more than 1 sentinel node not detected coherently by the tracers.

Detailed description

Number of higher-echelon nodes visualized on preoperative lymphoscintigraphy and SPECT/CT imaging for both tracers (ICG-99mTc-Nanoscan and 99mTc-Nanoscan); 99mTc-Nanoscan is used as reference tracer., Concordance between intraoperative fluorescence and radioactive findings, using:  Number and intensity of the fluorescent nodes at time of excision;  Number and radioactive signal intensity of the radioactive nodes at time of excision

Interventions

DRUGINDOCYANINE GREEN

Sponsors

Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
To demonstrate concordance between the SN visualization of 99mTc-nanoscan and ICG-99mTc-nanoscan on preoperative lymphoscintigraphy and SPECT/CT imaging, expecting an average of 3 sentinel nodes per patient. Discordance is defined as more than 1 sentinel node not detected coherently by the tracers.

Secondary

MeasureTime frame
Number of higher-echelon nodes visualized on preoperative lymphoscintigraphy and SPECT/CT imaging for both tracers (ICG-99mTc-Nanoscan and 99mTc-Nanoscan); 99mTc-Nanoscan is used as reference tracer., Concordance between intraoperative fluorescence and radioactive findings, using:  Number and intensity of the fluorescent nodes at time of excision;  Number and radioactive signal intensity of the radioactive nodes at time of excision

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026